Quantbot Technologies’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $446K | Buy |
+7,851
| New | +$348K | 0.02% | 972 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$894 | – | 2007 |
|
|
2023
Q3 | $894 | Buy |
+100
| New | +$1.41K | ﹤0.01% | 1476 |
|
|
2023
Q2 | – | Sell |
-16,700
| Closed | -$376K | – | 1967 |
|
|
2023
Q1 | $376K | Buy |
+16,700
| New | +$355K | 0.03% | 706 |
|
|
2022
Q3 | – | Sell |
-6,500
| Closed | -$157K | – | 2110 |
|
|
2022
Q2 | $157K | Buy |
+6,500
| New | +$163K | 0.01% | 1010 |
|
|
2022
Q1 | – | Sell |
-341
| Closed | -$10K | – | 2058 |
|
|
2021
Q4 | $10K | Buy |
+341
| New | +$9.6K | ﹤0.01% | 1313 |
|
|
2021
Q3 | – | Sell |
-887
| Closed | -$12K | – | 1913 |
|
|
2021
Q2 | $12K | Buy |
+887
| New | +$17.5K | ﹤0.01% | 1294 |
|
|
2019
Q4 | – | Sell |
-1,250
| Closed | -$14K | – | 1599 |
|
|
2019
Q3 | $14K | Buy |
1,250
+950
| +317% | +$15.7K | ﹤0.01% | 1148 |
|
|
2019
Q2 | $6K | Buy |
+300
| New | +$5.92K | ﹤0.01% | 1118 |
|
|
2018
Q3 | – | Sell |
-2,870
| Closed | -$78K | – | 1556 |
|
|
2018
Q2 | $78K | Sell |
2,870
-2,088
| -42% | -$55.6K | 0.01% | 919 |
|
|
2018
Q1 | $110K | Buy |
+4,958
| New | +$118K | 0.01% | 823 |
|
|
2017
Q4 | – | Sell |
-2,683
| Closed | -$66K | – | 1492 |
|
|
2017
Q3 | $66K | Buy |
+2,683
| New | +$59.1K | 0.01% | 920 |
|
|
2017
Q2 | – | Sell |
-3,355
| Closed | -$61K | – | 1392 |
|
|
2017
Q1 | $61K | Sell |
3,355
-2,258
| -40% | -$44.2K | 0.01% | 883 |
|
|
2016
Q4 | $106K | Buy |
5,613
+1,790
| +47% | +$36.6K | 0.01% | 700 |
|
|
2016
Q3 | $85K | Buy |
3,823
+713
| +23% | +$13.6K | 0.01% | 753 |
|
|
2016
Q2 | $55K | Sell |
3,110
-726
| -19% | -$11.8K | 0.01% | 815 |
|
|
2016
Q1 | $52K | Buy |
+3,836
| New | +$58.2K | 0.01% | 863 |
|
|
2015
Q4 | – | Sell |
-500
| Closed | -$10K | – | 1377 |
|
|
2015
Q3 | $10K | Sell |
500
-400
| -44% | -$11.8K | ﹤0.01% | 1087 |
|
|
2015
Q2 | $29K | Buy |
+900
| New | +$24.6K | 0.01% | 901 |
|
|
2015
Q1 | – | Sell |
-200
| Closed | -$2K | – | 1359 |
|
|
2014
Q4 | $2K | Buy |
+200
| New | +$2.07K | ﹤0.01% | 1066 |
|
Other funds holding TVTX
JT
PA
NAMI
Quantbot Technologies's TVTX Position: Q2 2026 in Review
Quantbot Technologies opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 7,851 shares worth $446K. The stake represents 0.02% of the portfolio and ranks #972 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in TVTX as recently as Q3 2023.
Quantbot Technologies first reported a position in TVTX in Q4 2014 and has held it in 19 quarters since. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- Quantbot Technologies held 7,851 shares of Travere Therapeutics worth $446K as of Q2 2026.
- Travere Therapeutics was a new Quantbot Technologies position in Q2 2026.
- Travere Therapeutics made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #972 holding.
- Quantbot Technologies first reported a position in Travere Therapeutics in Q4 2014 and has held it in 19 quarters since.
- 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.